BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shivaswamy V, Boerner B, Larsen J. Post-Transplant Diabetes Mellitus: Causes, Treatment, and Impact on Outcomes. Endocr Rev. 2016;37:37-61. [PMID: 26650437 DOI: 10.1210/er.2015-1084] [Cited by in Crossref: 158] [Cited by in F6Publishing: 166] [Article Influence: 19.8] [Reference Citation Analysis]
Number Citing Articles
1 van Wilpe R, Hulst AH, Siegelaar S, Devries JH, Preckel B, Hermanides J. Type 1 and other types of diabetes mellitus in the perioperative period. What the anaesthetist should know. Journal of Clinical Anesthesia 2023;84:111012. [DOI: 10.1016/j.jclinane.2022.111012] [Reference Citation Analysis]
2 Courbebaisse M, Bourmaud A, Souberbielle JC, Sberro-Soussan R, Moal V, Le Meur Y, Kamar N, Albano L, Thierry A, Dantal J, Danthu C, Moreau K, Morelon E, Heng AE, Bertrand D, Arzouk N, Perrin P, Morin MP, Rieu P, Presne C, Grimbert P, Ducloux D, Büchler M, Le Quintrec M, Ouali N, Pernin V, Bouvier N, Durrbach A, Alamartine E, Randoux C, Besson V, Hazzan M, Pages J, Colas S, Piketty ML, Friedlander G, Prié D, Alberti C, Thervet E. Nonskeletal and skeletal effects of high doses versus low doses of vitamin D(3) in renal transplant recipients: Results of the VITALE (VITamin D supplementation in renAL transplant recipients) study, a randomized clinical trial. Am J Transplant 2023:S1600-6135(22)29286-7. [PMID: 36695682 DOI: 10.1016/j.ajt.2022.12.007] [Reference Citation Analysis]
3 ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D, Collins BS, Hilliard ME, Isaacs D, Johnson EL, Kahan S, Khunti K, Leon J, Lyons SK, Perry ML, Prahalad P, Pratley RE, Seley JJ, Stanton RC, Gabbay RA, on behalf of the American Diabetes Association. 2. Classification and Diagnosis of Diabetes: Standards of Care in Diabetes-2023. Diabetes Care 2023;46:S19-40. [PMID: 36507649 DOI: 10.2337/dc23-S002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
4 Struja T, Nitritz N, Alexander I, Kupferschmid K, Hafner JF, Spagnuolo CC, Schuetz P, Mueller B, Blum CA. Treatment of Glucocorticoid- induced hyperglycemia in hospitalized patients - A Systematic Review and Meta- Analysis.. [DOI: 10.21203/rs.3.rs-2194086/v1] [Reference Citation Analysis]
5 Kang E, Lee J, Kang DH, Park J, Park S, Kim YC, Kim DK, Joo KW, Kim YS, Park M, Lim Y, Lee H. Clinical outcomes of posttransplantation diabetes mellitus in kidney transplantation recipients: a nationwide population-based cohort study in Korea. Sci Rep 2022;12:21632. [PMID: 36517524 DOI: 10.1038/s41598-022-25070-z] [Reference Citation Analysis]
6 Petrosan A, Santeusanio AD, Khaim R, Delaney V. Comparison of Intensive Insulin Versus Oral Regimens on Early Glycemic Control Following Kidney Transplant. Prog Transplant 2022;32:327-31. [PMID: 36114645 DOI: 10.1177/15269248221122869] [Reference Citation Analysis]
7 Qin L, Chen S, Xie L, Yu Q, Chen Y, Xie J. Recent advances in Mung bean polysaccharides: Extraction, physicochemical properties and biological activities. Process Biochemistry 2022;121:248-56. [DOI: 10.1016/j.procbio.2022.07.014] [Reference Citation Analysis]
8 Wang W, Tan J, Nima L, Sang Y, Cai X, Xue H. Polysaccharides from fungi: A review on their extraction, purification, structural features, and biological activities. Food Chemistry: X 2022;15:100414. [DOI: 10.1016/j.fochx.2022.100414] [Reference Citation Analysis]
9 Wang L, Huang J, Li Y, Shi K, Gao S, Zhao W, Zhang S, Ding C, Gao W. Postoperative fasting plasma glucose and family history diabetes mellitus can predict post-transplantation diabetes mellitus in kidney transplant recipients.. [DOI: 10.21203/rs.3.rs-2044364/v1] [Reference Citation Analysis]
10 Reggiani F, Moroni G, Ponticelli C. Cardiovascular Risk after Kidney Transplantation: Causes and Current Approaches to a Relevant Burden. JPM 2022;12:1200. [DOI: 10.3390/jpm12081200] [Reference Citation Analysis]
11 Zhou Y, Xu B. New insights into anti-diabetes effects and molecular mechanisms of dietary saponins. Crit Rev Food Sci Nutr 2022;:1-26. [PMID: 35866515 DOI: 10.1080/10408398.2022.2101425] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Newman JD, Schlendorf KH, Cox ZL, Zalawadiya SK, Powers AC, Niswender KD, Shah RV, Lindenfeld J. Post-transplant diabetes mellitus following heart transplantation. The Journal of Heart and Lung Transplantation 2022. [DOI: 10.1016/j.healun.2022.07.011] [Reference Citation Analysis]
13 Bakhdar FA, Abdel kawy HS, Magadmi RM, El-kordy EA, Alamri AS. Effect of histone deacetylase inhibitor (vorinostat) on new-onset diabetes induced by tacrolimus. Journal of Taibah University Medical Sciences 2022. [DOI: 10.1016/j.jtumed.2022.07.004] [Reference Citation Analysis]
14 Vinson AJ, Thanamayooran A, Kiberd BA, West K, Siddiqi FS, Gunaratnam L, Tennankore KK. The Association of Pre-Transplant C-Peptide Level with the Development of Post-Transplant Diabetes: A Cohort Study. Kidney360 2022;3:1738-45. [PMID: 36514718 DOI: 10.34067/KID.0003742022] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Rivinius R, Gralla C, Helmschrott M, Darche FF, Ehlermann P, Bruckner T, Sommer W, Warnecke G, Kopf S, Szendroedi J, Frey N, Kihm LP. Pre-transplant Type 2 Diabetes Mellitus Is Associated With Higher Graft Failure and Increased 5-Year Mortality After Heart Transplantation. Front Cardiovasc Med 2022;9. [DOI: 10.3389/fcvm.2022.890359] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Marie A. Chisholm-Burns, Christina A. Spivey, Chi Chun Steve Tsang, Junling Wang. Racial/Ethnic Disparities due to Medicare Part D Star Ratings Criteria among Renal Transplant Recipients with Diabetes, Hypertension, and/or Dyslipidemia. J Manag Care Spec Pharm 2022;28. [PMID: 35621720 DOI: 10.18553/jmcp.2022.28.6.688] [Reference Citation Analysis]
17 Cheng F, Li Q, Wang J, Wang Z, Zeng F, Zhang Y. Analysis of risk factors and establishment of a risk prediction model for post-transplant diabetes mellitus after kidney transplantation. Saudi Pharmaceutical Journal 2022. [DOI: 10.1016/j.jsps.2022.05.013] [Reference Citation Analysis]
18 Lemke A, Brokmeier HM, Leung SB, Mara KC, Mour GK, Wadei HM, Hill JM, Stegall M, Kudva YC, Shah P, Kukla A. Sodium-glucose cotransporter 2 inhibitors for treatment of diabetes mellitus after kidney transplantation. Clin Transplant 2022;:e14718. [PMID: 35593882 DOI: 10.1111/ctr.14718] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
19 Clemens KK, Brahmania M, Weernink C, Lofty K, Rjoob H, Berberich A, Gob A. Reducing hyperglycaemia post-kidney and liver transplant: a quality improvement initiative. BMJ Open Qual 2022;11:e001796. [PMID: 35577401 DOI: 10.1136/bmjoq-2021-001796] [Reference Citation Analysis]
20 Cheng F, Li Q, Wang J, Wang Z, Zeng F, Zhang Y. Retrospective Analysis of the Risk Factors of Perioperative Bacterial Infection and Correlation with Clinical Prognosis in Kidney Transplant Recipients. Infect Drug Resist 2022;15:2271-86. [PMID: 35510155 DOI: 10.2147/IDR.S356543] [Reference Citation Analysis]
21 Kim JG, Jun JH. Therapeutic and tectonic keratoplasty with simple cryopreserved remnants of donor corneas: an 11 year retrospective case series. Sci Rep 2022;12:7331. [PMID: 35513446 DOI: 10.1038/s41598-022-10994-3] [Reference Citation Analysis]
22 Miyazaki R, Miyagi K. Empagliflozin in kidney transplant recipients with chronic kidney disease G3a-4 and metabolic syndrome: Five Japanese cases. BMC Nephrol 2022;23:168. [PMID: 35501824 DOI: 10.1186/s12882-022-02793-9] [Reference Citation Analysis]
23 Dos Santos Q, Hornum M, Terrones-Campos C, Crone CG, Wareham NE, Soeborg A, Rasmussen A, Gustafsson F, Perch M, Soerensen SS, Lundgren J, Feldt-Rasmussen B, Reekie J. Posttransplantation Diabetes Mellitus Among Solid Organ Recipients in a Danish Cohort. Transpl Int 2022;35:10352. [PMID: 35449717 DOI: 10.3389/ti.2022.10352] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
24 Rose Epstein F, Trammell J, Liu CM, Denhaerynck K, Dobbels F, Russell C, De Geest S. A Secondary Analysis from The International BRIGHT Study For Gender Differences In Adherence To Nonpharmacological Health-Related Behaviors After Heart Transplantation. Prog Transplant 2022;:15269248221087435. [PMID: 35331039 DOI: 10.1177/15269248221087435] [Reference Citation Analysis]
25 Willigenburg HV, Domburg BV, Ambagtsheer G, Brandt RM, Hesselink DA, de Bruin RW, de Winter BC. Validation of a dried blood spot method to measure tacrolimus concentrations in small volumes of mouse blood. Bioanalysis 2022. [PMID: 35289217 DOI: 10.4155/bio-2021-0247] [Reference Citation Analysis]
26 Sirch C, Khanna N, Frassetto L, Bianco F, Artero ML. Diagnosis of acute intermittent porphyria in a renal transplant patient: A case report. World J Transplant 2022; 12(1): 8-14 [DOI: 10.5500/wjt.v12.i1.8] [Reference Citation Analysis]
27 Ducloux D, Courivaud C. Prevention of Post-Transplant Diabetes Mellitus: Towards a Personalized Approach. JPM 2022;12:116. [DOI: 10.3390/jpm12010116] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
28 Axelrod DA, Cheungpasitporn W, Bunnapradist S, Schnitzler MA, Xiao H, Mcadams-demarco M, Caliskan Y, Bae S, Ahn JB, Segev DL, Lam NN, Hess GP, Lentine KL. Posttransplant Diabetes Mellitus and Immunosuppression Selection in Older and Obese Kidney Recipients. Kidney Medicine 2022;4:100377. [DOI: 10.1016/j.xkme.2021.08.012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
29 Bashier AM, Kumar D, Alalawi FJ, Al Nour H, Al Hadari AK, Bin Hussain AA. Post-Transplant Diabetes: Prevalence, Risk, and Management Challenges. Dubai Diabetes Endocrinol J 2022;28:79-92. [DOI: 10.1159/000522092] [Reference Citation Analysis]
30 Bhattarai M, Bhayana S. Post-Transplant Diabetes Mellitus. Complications in Kidney Transplantation 2022. [DOI: 10.1007/978-3-031-13569-9_61] [Reference Citation Analysis]
31 Ahn JB, Bae S, Schnitzler M, Hess GP, Lentine KL, Segev DL, McAdams-DeMarco MA. Effect of Early Steroid Withdrawal on Posttransplant Diabetes Among Kidney Transplant Recipients Differs by Recipient Age. Transplant Direct 2022;8:e1260. [PMID: 34912947 DOI: 10.1097/TXD.0000000000001260] [Reference Citation Analysis]
32 Dashti-Khavidaki S, Saidi R, Lu H. Current status of glucocorticoid usage in solid organ transplantation. World J Transplant 2021; 11(11): 443-465 [PMID: 34868896 DOI: 10.5500/wjt.v11.i11.443] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
33 Tantisattamo E, Kalantar-Zadeh K. Editorial: Novel therapeutic approaches in chronic kidney disease, uremia and kidney transplantation: past, present and future. Curr Opin Nephrol Hypertens 2021;30:1-4. [PMID: 33186225 DOI: 10.1097/MNH.0000000000000677] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
34 Mohamed IB, Aloor FZ, Jalal PK. Strategies to Improve Immune Suppression Post-Liver Transplantation: A Review. Transplantology 2021;2:441-54. [DOI: 10.3390/transplantology2040042] [Reference Citation Analysis]
35 Martinez Cantarin MP. Diabetes in Kidney Transplantation. Adv Chronic Kidney Dis 2021;28:596-605. [PMID: 35367028 DOI: 10.1053/j.ackd.2021.10.004] [Reference Citation Analysis]
36 Lin H, Yan J, Yuan L, Qi B, Zhang Z, Zhang W, Ma A, Ding F. Impact of diabetes mellitus developing after kidney transplantation on patient mortality and graft survival: a meta-analysis of adjusted data. Diabetol Metab Syndr 2021;13:126. [PMID: 34717725 DOI: 10.1186/s13098-021-00742-4] [Reference Citation Analysis]
37 Hoeyrup N, Spillmann T, Toresson L. Cyclosporine Treatment in Cats with Presumed Chronic Pancreatitis-A Retrospective Study. Animals (Basel) 2021;11:2993. [PMID: 34680012 DOI: 10.3390/ani11102993] [Reference Citation Analysis]
38 Azhie A, Sheth P, Hammad A, Woo M, Bhat M. Metabolic Complications in Liver Transplantation Recipients: How We Can Optimize Long-Term Survival. Liver Transpl 2021;27:1468-78. [PMID: 34165872 DOI: 10.1002/lt.26219] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
39 Bulbuloglu S, Kapikiran G. The effect of immunosuppressive therapy after liver transplantation on activities of daily living and fear of death during the COVID-19 pandemic. Transpl Immunol 2021;69:101470. [PMID: 34555504 DOI: 10.1016/j.trim.2021.101470] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
40 Iqbal A, Zhou K, Kashyap SR, Lansang MC. Approach to the patient: Early post-renal transplant hyperglycemia. J Clin Endocrinol Metab 2021:dgab697. [PMID: 34558599 DOI: 10.1210/clinem/dgab697] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
41 Demir B, Bulbuloglu S. The effect of immunosuppression therapy on activities of daily living and comfort level after liver transplantation. Transpl Immunol 2021;69:101468. [PMID: 34536554 DOI: 10.1016/j.trim.2021.101468] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
42 Missikpode C, Durazo-Arvizu RA, Cooper RS, OʼBrien MJ, Castaneda SF, Talavera GA, Gallo LC, Llabre MM, Perera MJ, Perreira KM, Ricardo AC, Pirzada A, Lash JP, Daviglus M. Cardiovascular disease and risk of incident diabetes mellitus: Findings from the Hispanic Community Health Study/Study of Latinos (HCHS/SOL). J Diabetes 2021;13:1043-53. [PMID: 34536057 DOI: 10.1111/1753-0407.13224] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
43 Ni Q, Song J, Wang Y, Sun J, Xie J, Zhang J, Ning G, Wang W, Wang Q. Proper mTORC1 Activity Is Required for Glucose Sensing and Early Adaptation in Human Pancreatic β Cells. J Clin Endocrinol Metab 2021;106:e562-72. [PMID: 33120423 DOI: 10.1210/clinem/dgaa786] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
44 Malik RF, Jia Y, Mansour SG, Reese PP, Hall IE, Alasfar S, Doshi MD, Akalin E, Bromberg JS, Harhay MN, Mohan S, Muthukumar T, Schröppel B, Singh P, Weng FL, Thiessen Philbrook HR, Parikh CR. Post-transplant Diabetes Mellitus in Kidney Transplant Recipients: A Multicenter Study. Kidney360 2021;2:1296-307. [PMID: 35369651 DOI: 10.34067/KID.0000862021] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
45 Siren EMJ, Luo HD, Tam F, Montgomery A, Enns W, Moon H, Sim L, Rey K, Guan Q, Wang JJ, Wardell CM, Monajemi M, Mojibian M, Levings MK, Zhang ZJ, Du C, Withers SG, Choy JC, Kizhakkedathu JN. Prevention of vascular-allograft rejection by protecting the endothelial glycocalyx with immunosuppressive polymers. Nat Biomed Eng 2021. [PMID: 34373602 DOI: 10.1038/s41551-021-00777-y] [Reference Citation Analysis]
46 Cheng F, Li Q, Wang J, Zeng F, Zhang Y. Effects and safety evaluation of Wuzhi Capsules combined with tacrolimus for the treatment of kidney transplantation recipients. J Clin Pharm Ther 2021. [PMID: 34342024 DOI: 10.1111/jcpt.13493] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
47 Arutyunyan VS, Keosyan AV, Firsov MA, Evdokimov DP, Tsokaev MR, Amelchugova OS, Lukicheva EV. Cadaveric kidney allotransplantation at Krasnoyarsk Regional Clinical Hospital. RJTAO 2021;23:41-51. [DOI: 10.15825/1995-1191-2021-2-41-51] [Reference Citation Analysis]
48 Ertuglu LA, Porrini E, Hornum M, Demiray A, Afsar B, Ortiz A, Covic A, Rossing P, Kanbay M. Glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter 2 inhibitors for diabetes after solid organ transplantation. Transpl Int 2021;34:1341-59. [PMID: 33880815 DOI: 10.1111/tri.13883] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
49 Job KM, Roberts JK, Enioutina EY, IIIamola SM, Kumar SS, Rashid J, Ward RM, Fukuda T, Sherbotie J, Sherwin CM. Treatment optimization of maintenance immunosuppressive agents in pediatric renal transplant recipients. Expert Opin Drug Metab Toxicol 2021;17:747-65. [PMID: 34121566 DOI: 10.1080/17425255.2021.1943356] [Reference Citation Analysis]
50 Lee LM, Zhang H, Lee K, Liang H, Merleev A, Vincenti F, Maverakis E, Thomson AW, Tang Q. A Comparison of Ex Vivo Expanded Human Regulatory T Cells Using Allogeneic Stimulated B Cells or Monocyte-Derived Dendritic Cells. Front Immunol 2021;12:679675. [PMID: 34220826 DOI: 10.3389/fimmu.2021.679675] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
51 Lawendy B, Srinathan S, Kotha S, Gomes C, Misra S, Yu J, Orchanian-Cheff A, Tomlinson G, Bhat M. Systematic review and meta-analysis of post-transplant diabetes mellitus in liver transplant recipients. Clin Transplant 2021;35:e14340. [PMID: 34033142 DOI: 10.1111/ctr.14340] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
52 Bhadada SK, Pal R. Post-liver transplantation diabetes mellitus — a clinical challenge for diabetologists? Int J Diabetes Dev Ctries. [DOI: 10.1007/s13410-021-00955-3] [Reference Citation Analysis]
53 Balashova AV, Mustafina VR, Glinkina IV. Interdisciplinary problem of post-transplant diabetes mellitus: literature review. jour 2021;12:60-73. [DOI: 10.47093/2218-7332.2021.12.1.60-73] [Reference Citation Analysis]
54 Sinha A, Loganathan S, S K, Mahanta A, P N, Bhattacharjee M. PATHOPHYSIOLOGY OF TYPE 2 DIABETES MELLITUS- CURRENT KNOWLEDGE AND RECENT ADVANCES: MINI REVIEW. ijsr 2021. [DOI: 10.36106/ijsr/5003168] [Reference Citation Analysis]
55 Culos KA, Gatwood KS. Immunosuppressive agents and monitoring in long‐term survivors. Blood and Marrow Transplantation Long Term Management 2021. [DOI: 10.1002/9781119612780.ch37] [Reference Citation Analysis]
56 Walker JT, Saunders DC, Brissova M, Powers AC. The Human Islet: Mini-organ with Mega-impact. Endocr Rev 2021:bnab010. [PMID: 33844836 DOI: 10.1210/endrev/bnab010] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 7.5] [Reference Citation Analysis]
57 Norrman AE, Tervahartiala T, Sahlberg E, Sorsa T, Ruokonen H, Grönroos L, Meurman JH, Isoniemi H, Nordin A, Åberg F, Helenius-Hietala J. Salivary Biomarkers and Oral Health in Liver Transplant Recipients, with an Emphasis on Diabetes. Diagnostics (Basel) 2021;11:662. [PMID: 33916950 DOI: 10.3390/diagnostics11040662] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
58 Do V, Haakinson D, Belfort-DeAguiar R, Cohen E. Implementing a pharmacist-led transition of care model for posttransplant hyperglycemia. Am J Health Syst Pharm 2021;78:1207-15. [PMID: 33821878 DOI: 10.1093/ajhp/zxab151] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
59 Suhecka K, Lejnieks A, Jušinskis J, Maļcevs A, Suhorukovs V, Amerika-ļebedjkova D, Straupmane D, Pētersons A, Ziediņa I. Early Correction of Post-Kidney Transplant Hyperglycaemia is Associated with Reduction of the Prevalence of Post-Transplant Diabetes Mellitus. Proceedings of the Latvian Academy of Sciences. Section B. Natural, Exact, and Applied Sciences. 2021;75:99-105. [DOI: 10.2478/prolas-2021-0016] [Reference Citation Analysis]
60 Rysz J, Franczyk B, Radek M, Ciałkowska-Rysz A, Gluba-Brzózka A. Diabetes and Cardiovascular Risk in Renal Transplant Patients. Int J Mol Sci 2021;22:3422. [PMID: 33810367 DOI: 10.3390/ijms22073422] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
61 Munshi VN, Saghafian S, Cook CB, Aradhyula SV, Chakkera HA. Use of Imputation and Decision Modeling to Improve Diagnosis and Management of Patients at Risk for New-Onset Diabetes After Transplantation. Ann Transplant 2021;26:e928624. [PMID: 33723204 DOI: 10.12659/AOT.928624] [Reference Citation Analysis]
62 Duque Escobar J, Kutschenko A, Schröder S, Blume R, Köster KA, Painer C, Lemcke T, Maison W, Oetjen E. Regulation of dual leucine zipper kinase activity through its interaction with calcineurin. Cell Signal 2021;82:109953. [PMID: 33600948 DOI: 10.1016/j.cellsig.2021.109953] [Reference Citation Analysis]
63 Liew ZH, Tan PH, Foo M, Kee T, Ho QY. Nodular glomerulosclerosis in a kidney transplant recipient with impaired glucose tolerance: diabetic or idiopathic? A case report and literature review. CEN Case Rep 2021;10:273-80. [PMID: 33393072 DOI: 10.1007/s13730-020-00546-x] [Reference Citation Analysis]
64 Subramaniam R. Anesthetic Concerns in Endocrine Cancers. Textbook of Onco-Anesthesiology 2021. [DOI: 10.1007/978-981-16-0006-7_17] [Reference Citation Analysis]
65 Cheng C, Feng Y, Wang H. Incidence and relative risk factors in posttransplant diabetes mellitus patients: a retrospective cohort study. Korean Journal of Transplantation 2020;34:231-237. [DOI: 10.4285/kjt.20.0026] [Reference Citation Analysis]
66 Chevallier E, Jouve T, Rostaing L, Malvezzi P, Noble J. pre-existing diabetes and PTDM in kidney transplant recipients: how to handle immunosuppression. Expert Rev Clin Pharmacol 2021;14:55-66. [PMID: 33196346 DOI: 10.1080/17512433.2021.1851596] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
67 Arafa N, Bazaraa HM, Sharaf ElDin H, Hussein M, Salah DM. Glucose tolerance in a cohort of Egyptian children after kidney transplantation. Diabetes Res Clin Pract 2021;172:108605. [PMID: 33333203 DOI: 10.1016/j.diabres.2020.108605] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
68 Abazari MF, Zare Karizi S, Hajati-Birgani N, Norouzi S, Khazeni Z, Hashemi J, Shafaghi L, Soleimanifar F, Mansour RN, Enderami SE. PHBV nanofibers promotes insulin-producing cells differentiation of human induced pluripotent stem cells. Gene 2021;768:145333. [PMID: 33278553 DOI: 10.1016/j.gene.2020.145333] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
69 Quinn WJ 3rd, Jiao J, TeSlaa T, Stadanlick J, Wang Z, Wang L, Akimova T, Angelin A, Schäfer PM, Cully MD, Perry C, Kopinski PK, Guo L, Blair IA, Ghanem LR, Leibowitz MS, Hancock WW, Moon EK, Levine MH, Eruslanov EB, Wallace DC, Baur JA, Beier UH. Lactate Limits T Cell Proliferation via the NAD(H) Redox State. Cell Rep 2020;33:108500. [PMID: 33326785 DOI: 10.1016/j.celrep.2020.108500] [Cited by in Crossref: 53] [Cited by in F6Publishing: 46] [Article Influence: 17.7] [Reference Citation Analysis]
70 Miyazaki R, Miyagi K, Yoshida M. Two Japanese patients with stage G3b chronic kidney disease and impaired glucose metabolism after renal transplantation successfully treated with empagliflozin. Ren Replace Ther 2020;6:55. [DOI: 10.1186/s41100-020-00303-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
71 Bhat M, Usmani SE, Azhie A, Woo M. Metabolic Consequences of Solid Organ Transplantation. Endocr Rev 2021;42:171-97. [PMID: 33247713 DOI: 10.1210/endrev/bnaa030] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
72 Hecking M, Sharif A, Eller K, Jenssen T. Management of post-transplant diabetes: immunosuppression, early prevention, and novel antidiabetics. Transpl Int. 2021;34:27-48. [PMID: 33135259 DOI: 10.1111/tri.13783] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 8.7] [Reference Citation Analysis]
73 Kukla A, Alexander MP, Turkevi-Nagy S, Merzkani M, Park W, Smith B, Zhang P, Benavides X, D'Costa M, Morales Alvarez C, Denic A, Bentall A, Kudva YC, Stegall M. Mesangial expansion at 5 years predicts death and death-censored graft loss after renal transplantation. Clin Transplant 2021;35:e14147. [PMID: 33170556 DOI: 10.1111/ctr.14147] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
74 Sanyal D, Biswas M, Chaudhari N. Long-term efficacy and safety of anti-hyperglycaemic agents in new-onset diabetes after transplant: Results from outpatient-based 1-year follow-up and a brief review of treatment options. Diabetes Metab Syndr. 2021;15:13-19. [PMID: 33278690 DOI: 10.1016/j.dsx.2020.11.019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
75 Chewcharat A, Prasitlumkum N, Thongprayoon C, Bathini T, Medaura J, Vallabhajosyula S, Cheungpasitporn W. Efficacy and Safety of SGLT-2 Inhibitors for Treatment of Diabetes Mellitus among Kidney Transplant Patients: A Systematic Review and Meta-Analysis. Med Sci (Basel). 2020;8. [PMID: 33213078 DOI: 10.3390/medsci8040047] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
76 Chen N, Zhang H, Zong X, Li S, Wang J, Wang Y, Jin M. Polysaccharides from Auricularia auricula: Preparation, structural features and biological activities. Carbohydrate Polymers 2020;247:116750. [DOI: 10.1016/j.carbpol.2020.116750] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 8.0] [Reference Citation Analysis]
77 Thijssen M, Tacke F, Beller L, Deboutte W, Yinda KC, Nevens F, Laleman W, Van Ranst M, Pourkarim MR. Clinical relevance of plasma virome dynamics in liver transplant recipients. EBioMedicine 2020;60:103009. [PMID: 32979836 DOI: 10.1016/j.ebiom.2020.103009] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
78 Jiao W, Zhang Z, Xu Y, Gong L, Zhang W, Tang H, Zeng S, Zhang Q, Sun Z, Liu L, Hu X. Butyric acid normalizes hyperglycemia caused by the tacrolimus-induced gut microbiota. Am J Transplant 2020;20:2413-24. [PMID: 32243709 DOI: 10.1111/ajt.15880] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
79 Roper T, Harber M, Jones G, Pitceathly RDS, Salama AD. Delayed diagnoses of mitochondrial cytopathies in patients presenting with end stage kidney disease: two case reports. BMC Nephrol 2020;21:361. [PMID: 32838736 DOI: 10.1186/s12882-020-02002-5] [Reference Citation Analysis]
80 Heidari A. Synthesis of Fructose Biosensors and Progressing Their Efficiency Using Californium Colloidal Nanoparticles for Detecting Fructose and Triglycerides. adv sci engng med 2020;12:1002-1017. [DOI: 10.1166/asem.2020.2635] [Reference Citation Analysis]
81 Lo C, Toyama T, Oshima M, Jun M, Chin KL, Hawley CM, Zoungas S. Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. Cochrane Database Syst Rev. 2020;8:CD009966. [PMID: 32803882 DOI: 10.1002/14651858.cd009966.pub3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
82 Hoppmann N, Massoud O. Medical care of liver transplant patients. Expert Rev Gastroenterol Hepatol 2020;14:901-18. [PMID: 32684007 DOI: 10.1080/17474124.2020.1797483] [Reference Citation Analysis]
83 Cheng CY, Chen CH, Wu MF, Wu MJ, Chen JP, Liu YM, Hou YC, Wang HY. Risk Factors in and Long-Term Survival of Patients with Post-Transplantation Diabetes Mellitus: A Retrospective Cohort Study. Int J Environ Res Public Health 2020;17:E4581. [PMID: 32630562 DOI: 10.3390/ijerph17124581] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
84 Kharazmkia A, Ziaie S, Ahmadpoor P, Moradi O, Khoshdel A, Pour-reza-gholi F, Samavat S, Samadian F, Nafar M. A Triple-Blind Randomized Controlled Trial on Impacts of Pioglitazone on Oxidative Stress Markers in Diabetic Kidney Transplant Recipients. Shiraz E-Med J 2020;21. [DOI: 10.5812/semj.98656] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
85 Cigrovski Berkovic M, Virovic-Jukic L, Bilic-Curcic I, Mrzljak A. Post-transplant diabetes mellitus and preexisting liver disease - a bidirectional relationship affecting treatment and management. World J Gastroenterol 2020; 26(21): 2740-2757 [PMID: 32550751 DOI: 10.3748/wjg.v26.i21.2740] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
86 Roháľ T. Patient after kidney transplantation in outpatient internal clinic. Vnitr Lek 2020;66:e17-e21. [DOI: 10.36290/vnl.2020.075] [Reference Citation Analysis]
87 Fatourou EM, Tsochatzis EA. Management of metabolic syndrome and cardiovascular risk after liver transplantation. Lancet Gastroenterol Hepatol. 2019;4:731-741. [PMID: 31387736 DOI: 10.1016/s2468-1253(19)30181-5] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]
88 Aleksic S, Eisenberg R, Tsomos E, Zahedpour Anaraki S, Japp E, Upadhyay L, Mowrey WB, Akalin E, Zonszein J. Glycemic management and clinical outcomes in underserved minority kidney transplant recipients with type 2 and posttransplantation diabetes: A single-center retrospective study. Diabetes Res Clin Pract 2020;165:108221. [PMID: 32442553 DOI: 10.1016/j.diabres.2020.108221] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
89 Chan Chun Kong D, Akbari A, Malcolm J, Doyle MA, Hoar S. Determinants of Poor Glycemic Control in Patients with Kidney Transplants: A Single-Center Retrospective Cohort Study in Canada. Can J Kidney Health Dis 2020;7:2054358120922628. [PMID: 32477582 DOI: 10.1177/2054358120922628] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
90 Mizrahi N, Braun M, Ben Gal T, Rosengarten D, Kramer MR, Grossman A. Post-transplant diabetes mellitus: incidence, predicting factors and outcomes. Endocrine 2020;69:303-9. [PMID: 32418071 DOI: 10.1007/s12020-020-02339-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
91 Cohen E, Korah M, Callender G, Belfort de Aguiar R, Haakinson D. Metabolic Disorders with Kidney Transplant. Clin J Am Soc Nephrol 2020;15:732-42. [PMID: 32284323 DOI: 10.2215/CJN.09310819] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
92 Yeh H, Lin C, Li YR, Yen CL, Lee CC, Chen JS, Chen KH, Tian YC, Liu PH, Hsiao CC. Temporal trends of incident diabetes mellitus and subsequent outcomes in patients receiving kidney transplantation: a national cohort study in Taiwan. Diabetol Metab Syndr 2020;12:34. [PMID: 32368254 DOI: 10.1186/s13098-020-00541-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
93 Zhao T, Zhao Y, Zong A, Tang Y, Shi X, Zhou Y. Association of body mass index and fasting plasma glucose concentration with post-transplantation diabetes mellitus in Chinese heart transplant recipients. J Int Med Res 2020;48:300060520910629. [PMID: 32216552 DOI: 10.1177/0300060520910629] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
94 Rangaswami J, Mathew RO, Parasuraman R, Tantisattamo E, Lubetzky M, Rao S, Yaqub MS, Birdwell KA, Bennett W, Dalal P, Kapoor R, Lerma EV, Lerman M, McCormick N, Bangalore S, McCullough PA, Dadhania DM. Cardiovascular disease in the kidney transplant recipient: epidemiology, diagnosis and management strategies. Nephrol Dial Transplant 2019;34:760-73. [PMID: 30984976 DOI: 10.1093/ndt/gfz053] [Cited by in Crossref: 69] [Cited by in F6Publishing: 72] [Article Influence: 23.0] [Reference Citation Analysis]
95 Arabi Z, Ghalib B, Asmari I, Gafar M, Alam S, Abdulgadir M, AlShareef A, Rashidi A, Alruwaymi M, Altheaby A. Instructions for kidney recipients and donors (In English for medical providers and in Arabic for patients and donors). Avicenna J Med 2020;10:41-53. [PMID: 32110549 DOI: 10.4103/ajm.ajm_120_19] [Reference Citation Analysis]
96 Ahmed SH, Biddle K, Augustine T, Azmi S. Post-Transplantation Diabetes Mellitus. Diabetes Ther. 2020;11:779-801. [PMID: 32095994 DOI: 10.1007/s13300-020-00790-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 3.7] [Reference Citation Analysis]
97 Tuttle KR, McGill JB. Evidence-based treatment of hyperglycaemia with incretin therapies in patients with type 2 diabetes and advanced chronic kidney disease. Diabetes Obes Metab 2020;22:1014-23. [PMID: 32009296 DOI: 10.1111/dom.13986] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
98 Thangavelu T, Lyden E, Shivaswamy V. A Retrospective Study of Glucagon-Like Peptide 1 Receptor Agonists for the Management of Diabetes After Transplantation. Diabetes Ther 2020;11:987-94. [PMID: 32072430 DOI: 10.1007/s13300-020-00786-1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
99 Osté MCJ, Flores-Guerrero JL, Gruppen EG, Kieneker LM, Connelly MA, Otvos JD, Dullaart RPF, Bakker SJL. High Plasma Branched-Chain Amino Acids Are Associated with Higher Risk of Post-Transplant Diabetes Mellitus in Renal Transplant Recipients. J Clin Med 2020;9:E511. [PMID: 32069900 DOI: 10.3390/jcm9020511] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
100 Bellini MI, Koutroutsos K, Nananpragasam H, Deurloo E, Galliford J, Herbert PE. Obesity affects graft function but not graft loss in kidney transplant recipients. J Int Med Res 2020;48:300060519895139. [PMID: 31939322 DOI: 10.1177/0300060519895139] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
101 Dai C, Walker JT, Shostak A, Padgett A, Spears E, Wisniewski S, Poffenberger G, Aramandla R, Dean ED, Prasad N, Levy SE, Greiner DL, Shultz LD, Bottino R, Powers AC. Tacrolimus- and sirolimus-induced human β cell dysfunction is reversible and preventable. JCI Insight 2020;5:130770. [PMID: 31941840 DOI: 10.1172/jci.insight.130770] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 6.7] [Reference Citation Analysis]
102 Kukla A, Hill J, Merzkani M, Bentall A, Lorenz EC, Park WD, D'Costa M, Kudva YC, Stegall MD, Shah P. The Use of GLP1R Agonists for the Treatment of Type 2 Diabetes in Kidney Transplant Recipients. Transplant Direct. 2020;6:e524. [PMID: 32095510 DOI: 10.1097/txd.0000000000000971] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
103 Khan SF, Bowman BT. Potassium disorders. Onco-Nephrology 2020. [DOI: 10.1016/b978-0-323-54945-5.00012-6] [Reference Citation Analysis]
104 Martínez-juárez I. Alteraciones del metabolismo de la glucosa en donante y receptor. Revista Mexicana de Trasplantes 2020;9:99-103. [DOI: 10.35366/93494] [Reference Citation Analysis]
105 Pieloch D. Kidney Transplantation. Nutrition in Kidney Disease 2020. [DOI: 10.1007/978-3-030-44858-5_18] [Reference Citation Analysis]
106 Manni A, Quarde A. Pancreatic Gland Signs. Endocrine Pathophysiology 2020. [DOI: 10.1007/978-3-030-49872-6_4] [Reference Citation Analysis]
107 Mekala KC, Bertoni AG. Epidemiology of diabetes mellitus. Transplantation, Bioengineering, and Regeneration of the Endocrine Pancreas 2020. [DOI: 10.1016/b978-0-12-814833-4.00004-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
108 Infante M, Padilla N, Madiraju S, Alvarez A, Baidal D, Ricordi C, Alejandro R. Combined liver and islet transplantation in hepatogenous diabetes, cluster exenteration, and cirrhosis with type 1 diabetes. Transplantation, Bioengineering, and Regeneration of the Endocrine Pancreas 2020. [DOI: 10.1016/b978-0-12-814833-4.00037-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
109 Chanchlani R, Kim SJ, Dixon SN, Jassal V, Banh T, Borges K, Vasilevska-Ristovska J, Paterson JM, Ng V, Dipchand A, Solomon M, Hebert D, Parekh RS. Incidence of new-onset diabetes mellitus and association with mortality in childhood solid organ transplant recipients: a population-based study. Nephrol Dial Transplant 2019;34:524-31. [PMID: 30060206 DOI: 10.1093/ndt/gfy213] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
110 Li L, Zhao H, Chen B, Fan Z, Li N, Yue J, Ye Q. FXR activation alleviates tacrolimus-induced post-transplant diabetes mellitus by regulating renal gluconeogenesis and glucose uptake. J Transl Med 2019;17:418. [PMID: 31836014 DOI: 10.1186/s12967-019-02170-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
111 Chen G, Gao L, Li X. Effects of exercise training on cardiovascular risk factors in kidney transplant recipients: a systematic review and meta-analysis. Ren Fail 2019;41:408-18. [PMID: 31106657 DOI: 10.1080/0886022X.2019.1611602] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
112 Londero TM, Giaretta LS, Farenzena LP, Manfro RC, Canani LH, Lavinsky D, Leitão CB, Bauer AC. Microvascular Complications of Posttransplant Diabetes Mellitus in Kidney Transplant Recipients: A Longitudinal Study. J Clin Endocrinol Metab 2019;104:557-67. [PMID: 30289492 DOI: 10.1210/jc.2018-01521] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
113 Falasinnu T, O'Shaughnessy MM, Troxell ML, Charu V, Weisman MH, Simard JF. A review of non-immune mediated kidney disease in systemic lupus erythematosus: A hypothetical model of putative risk factors. Semin Arthritis Rheum 2020;50:463-72. [PMID: 31866044 DOI: 10.1016/j.semarthrit.2019.10.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
114 Jomphe V, Nguyen C, Durette G, Chagnon M, Nasir B, Poirier C, Ferraro P, Lands LC, Mailhot G. Trends, Determinants, and Impact on Survival of Post-Lung Transplant Weight Changes: A Single-center Longitudinal Retrospective Study. Transplantation 2019;103:2614-23. [PMID: 31765365 DOI: 10.1097/TP.0000000000002696] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
115 Sidhaye A, Goldswieg B, Kaminski B, Blackman SM, Kelly A. Endocrine complications after solid-organ transplant in cystic fibrosis. Journal of Cystic Fibrosis 2019;18:S111-9. [DOI: 10.1016/j.jcf.2019.08.019] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
116 Matthews J, Eplin D, Savani B, Leon BGC, Matheny L. Managing Endocrine Disorders in Adults After Hematopoietic Stem Cell Transplantation. Clin Hematol Int 2019;1:180-8. [PMID: 34595429 DOI: 10.2991/chi.d.190917.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
117 Cajanding R. Immunosuppression following organ transplantation. Part 2: complications and their management. Br J Nurs 2018;27:1059-65. [PMID: 30281349 DOI: 10.12968/bjon.2018.27.18.1059] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
118 Carney KC, Bronzell-wynder T, Gronek K. Lung Transplant for the Critical Care Nurse. Critical Care Nursing Clinics of North America 2019;31:285-302. [DOI: 10.1016/j.cnc.2019.05.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
119 Paek JH, Kang SS, Park WY, Jin K, Park SB, Han S, Kim CD, Ro H, Lee S, Jung CW, Park JB, Huh KH, Yang J, Ahn C. Incidence of Post-transplantation Diabetes Mellitus Within 1 Year After Kidney Transplantation and Related Factors in Korean Cohort Study. Transplant Proc 2019;51:2714-7. [PMID: 31477423 DOI: 10.1016/j.transproceed.2019.02.054] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
120 Lim JH, Hwang I, Cho JH, Kwon E, Jung HY, Choi JY, Park SH, Kim YL, Kim HK, Huh S, Won DI, Kim CD. Impact of Conversion From Cyclosporine to Tacrolimus on Glucose Metabolism and Cardiovascular Risk Profiles in Long-Term Stable Kidney Transplant Recipients. Transplant Proc 2019;51:2697-703. [PMID: 31439330 DOI: 10.1016/j.transproceed.2019.04.081] [Reference Citation Analysis]
121 Garla V, Kanduri S, Yanes-cardozo L, Lién LF. Management of diabetes mellitus in chronic kidney disease. Minerva Endocrinol 2019;44. [DOI: 10.23736/s0391-1977.19.03015-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
122 Tsai SF, Chen CH. Management of Diabetes Mellitus in Normal Renal Function, Renal Dysfunction and Renal Transplant Recipients, Focusing on Glucagon-Like Peptide-1 Agonist: A Review Based upon Current Evidence. Int J Mol Sci. 2019;20. [PMID: 31261624 DOI: 10.3390/ijms20133152] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
123 Shimada H, Uchida J, Nishide S, Kabei K, Kosoku A, Maeda K, Iwai T, Naganuma T, Takemoto Y, Nakatani T. Comparison of Glucose Tolerance between Kidney Transplant Recipients and Healthy Controls. J Clin Med 2019;8:E920. [PMID: 31252561 DOI: 10.3390/jcm8070920] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
124 Mota-Zamorano S, Luna E, Garcia-Pino G, González LM, Gervasini G. Variability in the leptin receptor gene and other risk factors for post-transplant diabetes mellitus in renal transplant recipients. Ann Med 2019;51:164-73. [PMID: 31046466 DOI: 10.1080/07853890.2019.1614656] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
125 Carminatti M, Tedesco-Silva H, Silva Fernandes NM, Sanders-Pinheiro H. Chronic kidney disease progression in kidney transplant recipients: A focus on traditional risk factors. Nephrology (Carlton) 2019;24:141-7. [PMID: 30159972 DOI: 10.1111/nep.13483] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
126 Malyala R, Rapi L, Nash MM, Prasad GVR. Serum Apolipoprotein B and A1 Concentrations Predict Late-Onset Posttransplant Diabetes Mellitus in Prevalent Adult Kidney Transplant Recipients. Can J Kidney Health Dis. 2019;6:2054358119850536. [PMID: 31205732 DOI: 10.1177/2054358119850536] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
127 Germani G, Laryea M, Rubbia-Brandt L, Egawa H, Burra P, OʼGrady J, Watt KD. Management of Recurrent and De Novo NAFLD/NASH After Liver Transplantation. Transplantation 2019;103:57-67. [PMID: 30335694 DOI: 10.1097/TP.0000000000002485] [Cited by in Crossref: 39] [Cited by in F6Publishing: 43] [Article Influence: 9.8] [Reference Citation Analysis]
128 Thiruvengadam S, Hutchison B, Lim W, Bennett K, Daniels G, Cusack N, Jacques A, Cawley B, Thiruvengadam S, Chakera A. Intensive monitoring for post-transplant diabetes mellitus and treatment with dipeptidyl peptidase-4 inhibitor therapy. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2019;13:1857-63. [DOI: 10.1016/j.dsx.2019.04.020] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
129 Lakhani OJ. Management of new onset diabetes after transplantation (NODAT) with use of novel algorithm. Int J Diabetes Dev Ctries 2019;39:768-73. [DOI: 10.1007/s13410-019-00741-2] [Reference Citation Analysis]
130 Bhattacharjee D, Vracar S, Round RA, Nightingale PG, Williams JA, Gkoutos GV, Stratton IM, Parker R, Luzio SD, Webber J, Manley SE, Roberts GA, Ghosh S. Utility of HbA1c assessment in people with diabetes awaiting liver transplantation. Diabet Med 2019;36:1444-52. [PMID: 30474191 DOI: 10.1111/dme.13870] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
131 Frost F, Dyce P, Ochota A, Pandya S, Clarke T, Walshaw MJ, Nazareth DS. Cystic fibrosis-related diabetes: optimizing care with a multidisciplinary approach. Diabetes Metab Syndr Obes 2019;12:545-52. [PMID: 31118718 DOI: 10.2147/DMSO.S180597] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
132 Bellini MI, Paoletti F, Herbert PE. Obesity and bariatric intervention in patients with chronic renal disease. J Int Med Res 2019;47:2326-41. [PMID: 31006298 DOI: 10.1177/0300060519843755] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
133 Nie H, Wang W, Zhao Y, Zhang X, Xiao Y, Zeng Q, Zhang C, Zhang L. New-Onset Diabetes After Renal Transplantation (NODAT): Is It a Risk Factor for Renal Cell Carcinoma or Renal Failure? Ann Transplant 2019;24:62-9. [PMID: 30713333 DOI: 10.12659/AOT.909099] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
134 Grancini V, Resi V, Palmieri E, Pugliese G, Orsi E. Management of diabetes mellitus in patients undergoing liver transplantation. Pharmacol Res. 2019;141:556-573. [PMID: 30690071 DOI: 10.1016/j.phrs.2019.01.042] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
135 Dedinská I, Graňák K, Vnučák M, Skálová P, Kováčiková L, Laca Ľ, Miklušica J, Prídavková D, Galajda P, Mokáň M. Role of sex in post-transplant diabetes mellitus development: Are men and women equal? J Diabetes Complications 2019;33:315-22. [PMID: 30755355 DOI: 10.1016/j.jdiacomp.2018.12.017] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
136 Dhital SM. Diabetes in Kidney Transplant Recipients. Kidney Transplant Management 2019. [DOI: 10.1007/978-3-030-00132-2_10] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
137 El Essawy B, Kandeel F. Pre, peri and posttransplant diabetes mellitus. Curr Opin Nephrol Hypertens 2019;28:47-57. [PMID: 30418189 DOI: 10.1097/MNH.0000000000000469] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
138 Iannino N, Nasri A, Räkel A, Ducharme A, Lachance K, Racine N, de Denus S, Tremblay-Gravel M, Fortier A, White M. Temporal Changes on the Risks and Complications of Posttransplantion Diabetes Mellitus Following Cardiac Transplantation. J Transplant 2018;2018:9205083. [PMID: 30533218 DOI: 10.1155/2018/9205083] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
139 Adrian T, Hornum M, Eriksson F, Hansen JM, Pilely K, Garred P, Feldt-Rasmussen B. Mannose-binding lectin genotypes and outcome in end-stage renal disease: a prospective cohort study. Nephrol Dial Transplant 2018;33:1991-7. [PMID: 29514287 DOI: 10.1093/ndt/gfy034] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
140 Wei X, Zhu D, Feng C, Chen G, Mao X, Wang Q, Wang J, Liu C. Inhibition of peptidyl-prolyl cis-trans isomerase B mediates cyclosporin A-induced apoptosis of islet β cells. Exp Ther Med 2018;16:3959-64. [PMID: 30344674 DOI: 10.3892/etm.2018.6706] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
141 Legendre C, Viebahn R, Fehrman-ekholm I, Masnou N, Berenguer M, Potena L, Wennberg L, O’grady J, Epailly E, Diekmann F, Binet I, Schwenger V, Kuypers D, Guthoff M. Long-term Challenges After Solid Organ Transplantation: Summary of Expert Presentations From the Sandoz 5th Standalone Transplantation Meeting, 2017. Transplantation 2018;102:S1-S14. [DOI: 10.1097/tp.0000000000002316] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
142 Xu J, Xu L, Wei X, Li X, Cai M. Incidence and Risk Factors of Posttransplantation Diabetes Mellitus in Living Donor Kidney Transplantation: A Single-Center Retrospective Study in China. Transplant Proc 2018;50:3381-5. [PMID: 30471834 DOI: 10.1016/j.transproceed.2018.08.007] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
143 Gomes V, Ferreira F, Guerra J, Bugalho MJ. New-onset diabetes after kidney transplantation: Incidence and associated factors. World J Diabetes 2018; 9(7): 132-137 [PMID: 30079149 DOI: 10.4239/wjd.v9.i7.132] [Cited by in CrossRef: 25] [Cited by in F6Publishing: 25] [Article Influence: 5.0] [Reference Citation Analysis]
144 Torres A, Hernández D, Moreso F, Serón D, Burgos MD, Pallardó LM, Kanter J, Díaz Corte C, Rodríguez M, Diaz JM, Silva I, Valdes F, Fernández-Rivera C, Osuna A, Gracia Guindo MC, Gómez Alamillo C, Ruiz JC, Marrero Miranda D, Pérez-Tamajón L, Rodríguez A, González-Rinne A, Alvarez A, Perez-Carreño E, de la Vega Prieto MJ, Henriquez F, Gallego R, Salido E, Porrini E. Randomized Controlled Trial Assessing the Impact of Tacrolimus Versus Cyclosporine on the Incidence of Posttransplant Diabetes Mellitus. Kidney Int Rep 2018;3:1304-15. [PMID: 30450457 DOI: 10.1016/j.ekir.2018.07.009] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 6.4] [Reference Citation Analysis]
145 Koloskova NN, Poptsov VN, Shevchenko AО. THE INDIVIDUAL TAILORING OF IMMUNOSUPPRESSIVE THERAPY AFTER HEART TRANSPLANTATION. RJTAO 2018;20:127-137. [DOI: 10.15825/1995-1191-2018-1-127-137] [Reference Citation Analysis]
146 Zhang X, Men T, Liu H, Li X, Wang J, Lv J. Genetic risk factors for post-transplantation diabetes mellitus in Chinese Han renal allograft recipients treated with tacrolimus. Transpl Immunol 2018;49:39-42. [PMID: 29665413 DOI: 10.1016/j.trim.2018.04.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
147 Senior PA, AlMehthel M, Miller A, Paty BW; Diabetes Canada Clinical Practice Guidelines Expert Committee. Diabetes and Transplantation. Can J Diabetes 2018;42 Suppl 1:S145-9. [PMID: 29650087 DOI: 10.1016/j.jcjd.2017.10.017] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
148 Liou JH, Liu YM, Chen CH. Management of Diabetes Mellitus With Glucagonlike Peptide-1 Agonist Liraglutide in Renal Transplant Recipients: A Retrospective Study. Transplant Proc. 2018;50:2502-2505. [PMID: 30316386 DOI: 10.1016/j.transproceed.2018.03.087] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 4.2] [Reference Citation Analysis]
149 Kaundal U, Bagai U, Rakha A. Immunomodulatory plasticity of mesenchymal stem cells: a potential key to successful solid organ transplantation. J Transl Med 2018;16:31. [PMID: 29448956 DOI: 10.1186/s12967-018-1403-0] [Cited by in Crossref: 41] [Cited by in F6Publishing: 43] [Article Influence: 8.2] [Reference Citation Analysis]
150 Peláez-Jaramillo MJ, Cárdenas-Mojica AA, Gaete PV, Mendivil CO. Post-Liver Transplantation Diabetes Mellitus: A Review of Relevance and Approach to Treatment. Diabetes Ther 2018;9:521-43. [PMID: 29411291 DOI: 10.1007/s13300-018-0374-8] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 8.2] [Reference Citation Analysis]
151 Brahmbhatt Y. Medical Complications After Kidney Transplantation: Early. Contemporary Kidney Transplantation 2018. [DOI: 10.1007/978-3-319-19617-6_14] [Reference Citation Analysis]
152 Brahmbhatt Y. Medical Complications After Kidney Transplantation: Early. Contemporary Kidney Transplantation 2018. [DOI: 10.1007/978-3-319-14779-6_14-1] [Reference Citation Analysis]
153 Lombardi A, Gambardella J, Du XL, Sorriento D, Mauro M, Iaccarino G, Trimarco B, Santulli G. Sirolimus induces depletion of intracellular calcium stores and mitochondrial dysfunction in pancreatic beta cells. Sci Rep. 2017;7:15823. [PMID: 29158477 DOI: 10.1038/s41598-017-15283-y] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 4.3] [Reference Citation Analysis]
154 Langsford D, Steinberg A, Dwyer KM. Diabetes Mellitus Following Renal Transplantation: Clinical and Pharmacological Considerations for the Elderly Patient. Drugs Aging 2017;34:589-601. [PMID: 28718072 DOI: 10.1007/s40266-017-0478-2] [Reference Citation Analysis]
155 Tarnowski M, Słuczanowska-Głabowska S, Pawlik A, Mazurek-Mochol M, Dembowska E. Genetic factors in pathogenesis of diabetes mellitus after kidney transplantation. Ther Clin Risk Manag 2017;13:439-46. [PMID: 28435278 DOI: 10.2147/TCRM.S129327] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
156 Adegunsoye A, Strek ME, Garrity E, Guzy R, Bag R. Comprehensive Care of the Lung Transplant Patient. Chest 2017;152:150-64. [PMID: 27729262 DOI: 10.1016/j.chest.2016.10.001] [Cited by in Crossref: 40] [Cited by in F6Publishing: 28] [Article Influence: 5.7] [Reference Citation Analysis]
157 Kang BJ, Park HW, Nah YW. Posttransplant Diabetes Mellitus after Liver Transplantation: Risk Factors for Persistence. Korean J Transplant 2016;30:125-132. [DOI: 10.4285/jkstn.2016.30.3.125] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
158 Han E, Kim MS, Kim YS, Kang ES. Risk assessment and management of post-transplant diabetes mellitus. Metabolism 2016;65:1559-69. [PMID: 27621191 DOI: 10.1016/j.metabol.2016.07.011] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
159 Constantinescu AA, Abbas M, Kassem M, Gleizes C, Kreutter G, Schini-Kerth V, Mitrea IL, Toti F, Kessler L. Differential influence of tacrolimus and sirolimus on mitochondrial-dependent signaling for apoptosis in pancreatic cells. Mol Cell Biochem 2016;418:91-102. [PMID: 27344165 DOI: 10.1007/s11010-016-2736-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]